These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34589366)

  • 1. Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia.
    Saito M; Morioka M; Izumiyama K; Mori A; Kondo T
    Cureus; 2021 Aug; 13(8):e17478. PubMed ID: 34589366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
    Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
    J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
    Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
    Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with thrombopoietin receptor agonist in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia.
    Khalafallah A; Rahman Z; Ogden K; Hannan T
    Mediterr J Hematol Infect Dis; 2012; 4(1):e2012003. PubMed ID: 22348185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eltrombopag-related renal vein thromboembolism in a patient with immune thrombocytopenia: A case report.
    Wu C; Zhou XM; Liu XD
    World J Clin Cases; 2021 Apr; 9(11):2611-2618. PubMed ID: 33889627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease.
    Skarsgard E; Doski J; Jaksic T; Wesson D; Shandling B; Ein S; Babyn P; Heiss K; Hu X
    J Pediatr Surg; 1993 Sep; 28(9):1109-12. PubMed ID: 8308671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
    Mori M; Kato M; Koh K; Hanada R
    Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic and Portal Vein Thrombosis after Splenectomy: A Case Report.
    Saliba T; Salame H; Tack D
    J Belg Soc Radiol; 2022; 106(1):126. PubMed ID: 36561436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.
    Wong RSM; Saleh MN; Khelif A; Salama A; Portella MSO; Burgess P; Bussel JB
    Blood; 2017 Dec; 130(23):2527-2536. PubMed ID: 29042367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report.
    Mohamed SE; Yassin MA
    Case Rep Oncol; 2020; 13(2):863-866. PubMed ID: 32884532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight on eltrombopag in treatment-refractory chronic primary immune thrombocytopenia.
    Garnock-Jones KP
    BioDrugs; 2011 Dec; 25(6):401-4. PubMed ID: 22050343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is ITP a thrombophilic disorder?
    Rodeghiero F
    Am J Hematol; 2016 Jan; 91(1):39-45. PubMed ID: 26547507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan.
    Ikeda M; Sekimoto M; Takiguchi S; Kubota M; Ikenaga M; Yamamoto H; Fujiwara Y; Ohue M; Yasuda T; Imamura H; Tatsuta M; Yano M; Furukawa H; Monden M
    Ann Surg; 2005 Feb; 241(2):208-16. PubMed ID: 15650628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag.
    Satoh T; Saotome M; Suwa K; Ohtani H; Nagata Y; Ono T; Maekawa Y
    Case Rep Cardiol; 2019; 2019():2756319. PubMed ID: 31049228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
    Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
    Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin receptor agonists as second-line therapy in splenectomy-eligible persistent immune thrombocytopenia: a case series.
    Vianello F; D'Amore F; Lombardi AM; Caputo I; Friziero A; Da Dalt G
    Blood Coagul Fibrinolysis; 2019 Sep; 30(6):295-299. PubMed ID: 31259778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Systemic Lysis Therapy of a Floating Carotid Thrombus in an Acute Stroke Patient with Known Immune Thrombocytopenia (ITP) on Ongoing Eltrombopag Therapy and Acute COVID-19 Infection: a Case Report.
    Adam LC; Burgstaller M; Taetweiler U; Mueller J
    SN Compr Clin Med; 2023; 5(1):133. PubMed ID: 37151759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study.
    Cheng G; Saleh MN; Marcher C; Vasey S; Mayer B; Aivado M; Arning M; Stone NL; Bussel JB
    Lancet; 2011 Jan; 377(9763):393-402. PubMed ID: 20739054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy.
    de'Angelis N; Abdalla S; Lizzi V; Esposito F; Genova P; Roy L; Galacteros F; Luciani A; Brunetti F
    Surgery; 2017 Dec; 162(6):1219-1230. PubMed ID: 28919051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.